APRE - Aprea Therapeutics announces one-for-twenty reverse stock split to meet Nasdaq compliance
- Aprea Therapeutics ( NASDAQ: APRE ) announced a one-for-twenty reverse stock split which became effective on February 10, 2023.
- The company’s stock will trade on the Nasdaq on a split-adjusted basis beginning on February 13, 2023, under the company’s existing trading symbol “APRE”.
- The reverse stock split as planned to increase the per share price of its stock to regain compliance with the listing requirements of the Nasdaq.
For further details see:
Aprea Therapeutics announces one-for-twenty reverse stock split to meet Nasdaq compliance